Oaklins’ media specialist team in New York acted as the exclusive financial advisor to the shareholders of Symbiotix, Inc. in the sale of the company to Havas Health, Inc., a world leading healthcare marketing network and a subsidiary company of Havas.
The team worked with management to define the marketplace positioning for Symbiotix Inc. and prepare the offering memorandum and other materials. Over 90 prospective buyers were contacted and the team led discussions with all parties and negotiated the deal with Havas Health.
Read more about the transaction, market trends, deal drivers and M&A valuation aspects in the attached newsletter.
© 2019 Oaklins. All rights reserved. Oaklins is the collective trade name of independent member firms affiliated with Oaklins International Inc. For details of the nature of affiliation, please refer to www.oaklins.com/legal.